When the Third Time Is Not the Charm—Trial Outcomes in Idiopathic Pulmonary Fibrosis
JAMA · 2024
DOI: 10.1001/jama.2024.8776 ↗Kurz gefasst
Editorial in der Zeitschrift JAMA, 2024. Verfasst von Ana C Zamora und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Respiratory Medicine, Mayo Clinic, Phoenix, Arizona. Hauptthemen laut MEDLINE: Idiopathic Pulmonary Fibrosis, Antibodies, Monoclonal, Humanized. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Division of Respiratory Medicine, Mayo Clinic, Phoenix, Arizona.
- Interstitial Lung Disease Clinic, Mayo Clinic, Phoenix, Arizona.
- Center for Individualized Medicine, Mayo Clinic, Phoenix, Arizona.
- Associate Editor, JAMA.
- Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota.
- Interstitial Lung Disease Clinic, Mayo Clinic, Rochester, Minnesota.
Zitieren
APA
Zamora, A. C., Ortega, V. E., & Carmona, E. M. (2024). When the Third Time Is Not the Charm—Trial Outcomes in Idiopathic Pulmonary Fibrosis. JAMA. https://doi.org/10.1001/jama.2024.8776
Vancouver
Zamora AC, Ortega VE, Carmona EM. When the Third Time Is Not the Charm—Trial Outcomes in Idiopathic Pulmonary Fibrosis. JAMA. 2024. doi:10.1001/jama.2024.8776
BibTeX
@article{Zamora2024,
author = {Zamora, Ana C and Ortega, Victor E and Carmona, Eva M},
title = {When the Third Time Is Not the Charm—Trial Outcomes in Idiopathic Pulmonary Fibrosis},
journal = {JAMA},
year = {2024},
doi = {10.1001/jama.2024.8776}
}
EUVIMED